Dr. Lal Path Labs · NSE: LALPATHLAB · BSE: 539524
Q3 FY23 results · Oct–Dec 2022
Dr. Lal Path Labs reported revenue from operations of ₹489.40 crore (down 1.5% from Q3 FY22) and net profit of ₹53.60 crore (down 7.9% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a consolidated basis.
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 489.40 | 496.90 | −1.5% | 533.80 | −8.3% |
| Other income | 10.50 | 12.10 | −13.2% | 8.70 | +20.7% |
| Total income | 499.90 | 509.00 | −1.8% | 542.50 | −7.9% |
| Profit before tax | 76.50 | 81.50 | −6.1% | 102.80 | −25.6% |
| Net profit for the period | 53.60 | 58.20 | −7.9% | 72.40 | −26.0% |
| Attributable to shareholders of the company | 52.80 | 57.30 | −7.9% | 71.70 | −26.4% |
| EPS, basic (₹) | 6.37 | 6.93 | −8.1% | 8.64 | −26.3% |
| Net margin (%) | 11.0 | 11.7 | 13.6 |
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 428.40 | 422.50 | +1.4% | 466.90 | −8.2% |
| Other income | 8.60 | 11.30 | −23.9% | 7.60 | +13.2% |
| Total income | 437.00 | 433.80 | +0.7% | 474.50 | −7.9% |
| Profit before tax | 84.10 | 83.20 | +1.1% | 106.40 | −21.0% |
| Net profit for the period | 62.40 | 61.70 | +1.1% | 78.60 | −20.6% |
| EPS, basic (₹) | 7.53 | 7.46 | +0.9% | 9.50 | −20.7% |
| Net margin (%) | 14.6 | 14.6 | 16.8 |
Consolidated
- Filed with BSE
- 02 Feb 2023, 18:12 IST
- Board meeting
- 02 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 02 Feb 2023, 18:12 IST
- Board meeting
- 02 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE